Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $0.53 Analyst target: $3.00 Upside: 466.04%
China Pharma Holdings, Inc. develops, manufactures and markets generic and branded pharmaceutical and biochemical products primarily for hospitals and private retailers in the People's Republic of China. The company is headquartered in Haikou, the People's Republic of China.
See the full interactive analysis & chart →Informational only — not investment advice.